View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
December 17, 2009

Radioactive “Bullet” Offers Hodgkin’s Lymphoma Hope

A radioactive "bullet" cancer therapy could offer a new treatment for Hodgkin's lymphoma patients after a successful experiment of the treatment. The new CHT25 therapy uses an antibody that targets tumour cells linked to a radioactive particle, according to The Telegraph.

By cms admin

A radioactive “bullet” cancer therapy could offer a new treatment for Hodgkin’s lymphoma patients after a successful experiment of the treatment.

The new CHT25 therapy uses an antibody that targets tumour cells linked to a radioactive particle, according to The Telegraph.

According to the results published in the journal Clinical Cancer Research, the treatment showed improvements in two thirds of the 15 patients involved with them either responding completely or partially to the drugs.

The UK’s Experimental Cancer Medicine Centre head of cancer research Prof Richard Begent who helped develop the treatment said that the initial results were very encouraging.

“There is an urgent need for new treatments for Hodgkin’s lymphoma and T-cell lymphoma because a number of patients develop drug resistance to the therapy options already out there,” Begent said.

The Phase II trial will be conducted at Cancer Research UK centres in London, Manchester and Southampton.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management